Cardiometabolic conditions such as heart attacks, stroke, type 2 diabetes, hypertension amongst others, are leading the causes of death globally, with its prevalence escalating every year. As most of these conditions are considerably attributed to reversible behaviours, there is a big opportunity to remotely prevent and manage the onset of cardiometabolic diseases and also enable regular, ongoing monitoring post diagnosis and treatment to improve health outcomes and reduce hospitalizations, emergency visits and in-office appointments.
What has been done so far in Virtual Care for cardiometabolic conditions? What are the main outcomes? Data validation and verification of Virtual Care solutions is key for different stakeholders (physicians, insurance, etc), but how are Virtual Care companies addressing this? Join this meeting to discuss this and more with other thought leaders in the space.